Annual Working Capital
$16.67 M
-$8.48 M-33.73%
31 December 2023
Summary:
Galera Therapeutics annual working capital is currently $16.67 million, with the most recent change of -$8.48 million (-33.73%) on 31 December 2023. During the last 3 years, it has fallen by -$47.29 million (-73.93%). GRTX annual working capital is now -84.55% below its all-time high of $107.88 million, reached on 31 December 2019.GRTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$9.84 M
-$3.34 M-25.33%
30 June 2024
Summary:
Galera Therapeutics quarterly working capital is currently $9.84 million, with the most recent change of -$3.34 million (-25.33%) on 30 June 2024. Over the past year, it has dropped by -$8.78 million (-47.16%). GRTX quarterly working capital is now -91.25% below its all-time high of $112.37 million, reached on 31 March 2020.GRTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GRTX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.7% | -47.2% |
| 3 y3 years | -73.9% | -87.2% |
| 5 y5 years | -78.5% | -84.4% |
GRTX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -74.1% | at low | -87.2% | at low |
| 5 y | 5 years | -84.5% | at low | -91.3% | at low |
| alltime | all time | -84.5% | +53.4% | -91.3% | at low |
Galera Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $9.84 M(-25.3%) |
| Mar 2024 | - | $13.17 M(-21.0%) |
| Dec 2023 | $16.67 M(-33.7%) | $16.67 M(-10.4%) |
| Sept 2023 | - | $18.61 M(-34.4%) |
| June 2023 | - | $28.38 M(-30.7%) |
| Mar 2023 | - | $40.98 M(+62.9%) |
| Dec 2022 | $25.16 M(-61.0%) | $25.16 M(-24.4%) |
| Sept 2022 | - | $33.28 M(-24.7%) |
| June 2022 | - | $44.20 M(-18.7%) |
| Mar 2022 | - | $54.34 M(-15.7%) |
| Dec 2021 | $64.46 M | $64.46 M(-16.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $76.96 M(-16.4%) |
| June 2021 | - | $92.02 M(+90.2%) |
| Mar 2021 | - | $48.38 M(-24.4%) |
| Dec 2020 | $63.96 M(-40.7%) | $63.96 M(-21.8%) |
| Sept 2020 | - | $81.80 M(-14.8%) |
| June 2020 | - | $96.00 M(-14.6%) |
| Mar 2020 | - | $112.37 M(+4.2%) |
| Dec 2019 | $107.88 M(+39.4%) | $107.88 M(+71.1%) |
| Sept 2019 | - | $63.06 M(-16.6%) |
| June 2019 | - | $75.60 M(-2.3%) |
| Dec 2018 | $77.41 M(+612.0%) | $77.41 M |
| Dec 2017 | $10.87 M | - |
FAQ
- What is Galera Therapeutics annual working capital?
- What is the all time high annual working capital for Galera Therapeutics?
- What is Galera Therapeutics annual working capital year-on-year change?
- What is Galera Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Galera Therapeutics?
- What is Galera Therapeutics quarterly working capital year-on-year change?
What is Galera Therapeutics annual working capital?
The current annual working capital of GRTX is $16.67 M
What is the all time high annual working capital for Galera Therapeutics?
Galera Therapeutics all-time high annual working capital is $107.88 M
What is Galera Therapeutics annual working capital year-on-year change?
Over the past year, GRTX annual working capital has changed by -$8.48 M (-33.73%)
What is Galera Therapeutics quarterly working capital?
The current quarterly working capital of GRTX is $9.84 M
What is the all time high quarterly working capital for Galera Therapeutics?
Galera Therapeutics all-time high quarterly working capital is $112.37 M
What is Galera Therapeutics quarterly working capital year-on-year change?
Over the past year, GRTX quarterly working capital has changed by -$8.78 M (-47.16%)